Ipamorelin vs Hexarelin: Which Ghrelin Mimetic?

Ipamorelin and hexarelin are both growth hormone releasing peptides (GHRPs) — ghrelin mimetics that tell your pituitary to pulse out growth hormone. On paper they do the same job. In practice they sit at opposite ends of a trade-off: hexarelin hits harder, ipamorelin behaves better. For most lifters, "behaves better" wins, but it's worth understanding exactly why, because the differences explain a lot about how the GHRP category evolved.

Same family, different personalities

A quick bit of background makes the comparison clearer. GHRPs work alongside the body's other GH-release lever, GHRH. Think of GH release as a car: GHRH (and analogs like CJC-1295) is the accelerator, somatostatin is the brake, and the GHRPs — ghrelin mimetics like ipamorelin and hexarelin — both press the accelerator and ease off the brake. That dual action is why GHRPs produce a strong pulse, and why they synergize so well when stacked with a GHRH analog. Both peptides in this comparison are doing that same fundamental job; they just differ in how cleanly they do it.

Both peptides activate the ghrelin receptor (GHSR) to trigger GH release, and both are typically paired with a GHRH analog like CJC-1295 for a stronger, more synergistic pulse. The difference is in their selectivity — how cleanly they do that one job versus how much else they stir up.

• Ipamorelin is the selective, clean one. It stimulates GH release with minimal effect on other hormones.
• Hexarelin is the potent but messy one. It's one of the strongest GH releasers in the class, but it doesn't stay in its lane — it also nudges cortisol and prolactin, and it desensitizes quickly.

That single distinction drives almost every practical difference between them.

Head to head

Potency

Hexarelin wins raw potency — it can produce a larger GH spike per dose than ipamorelin. If acute GH release were the only thing that mattered, hexarelin would look like the better tool. But acute potency isn't the same as a good outcome over a cycle, which is where hexarelin's problems show up.

Desensitization — hexarelin's fatal flaw

This is the dealbreaker for most people. Hexarelin desensitizes the ghrelin receptor quickly — your body stops responding to it after a few weeks of consistent use, and the GH release fades. We dug into the mechanism in why hexarelin desensitizes faster. Ipamorelin, by contrast, is far gentler on the receptor and can be run on a sustainable schedule without the same rapid tolerance. For a peptide you want to use for months, fast desensitization isn't a quirk — it's disqualifying.

Side-effect cleanliness

Ipamorelin's selectivity is its headline feature. It releases GH without meaningfully raising cortisol (the stress hormone you don't want chronically elevated) or prolactin (which can cause its own issues). Hexarelin raises both to a degree, which adds unwanted hormonal noise on top of the GH benefit. For anyone optimizing body composition and recovery, raising cortisol is working against yourself.

When hexarelin still makes sense

Hexarelin isn't useless — it's a specialist tool. Its potency and its separately-studied cardiac effects make it interesting for short, strategic use rather than as a daily driver. Some users deploy it in brief bursts to exploit the strong GH pulse before desensitization sets in, then rotate off. There's also a distinct research thread on hexarelin and cardiac tissue that's unrelated to its GH role, which we covered in hexarelin and cardiac protection. But "useful in short specialized bursts" is a narrow niche compared to ipamorelin's role as a sustainable workhorse.

Why ipamorelin became the default

The strength community largely converged on ipamorelin for the same reasons laid out above — it's the peptide that replaced the older, messier GHRPs (GHRP-2 and GHRP-6) precisely because of its clean profile, as we covered in how ipamorelin replaced GHRP-2 and -6. Hexarelin, despite being more potent, never became the default because potency without sustainability and cleanliness isn't actually what most users need. The ipamorelin protocol and the broader GHRP comparison put it in context.

The cortisol problem, in plain terms

It's worth dwelling on why hexarelin's cortisol effect is more than a footnote, because it gets glossed over in potency-focused comparisons. Cortisol is your primary stress hormone, and chronically elevated cortisol is directly counterproductive to everything a GH peptide is supposed to help with. It promotes muscle breakdown, encourages fat storage (especially visceral), impairs sleep quality, and blunts recovery.

So a peptide that releases more GH but also nudges cortisol up is, in a sense, fighting itself — giving you an anabolic/recovery signal with one hand while raising a catabolic/stress signal with the other. Ipamorelin's selectivity means you get the GH pulse without paying that tax. For most lifters, the GH released by either peptide is in a similar useful range once stacked with a GHRH analog, so the deciding factor isn't "who releases more GH" — it's "who does it without the hormonal collateral damage." That framing is why the raw-potency advantage of hexarelin matters far less than it first appears, and why the prolactin rise (which can affect mood and libido at higher levels) only adds to the case against routine use.

How people run them

This is education, not a prescription.

• Ipamorelin: typically dosed daily (often once or more), commonly stacked with CJC-1295, on a sustainable long-term schedule with periodic breaks. Timing around sleep or training is common — see best injection timing.
• Hexarelin: if used at all, in short blocks to front-run desensitization, with full awareness of the cortisol/prolactin trade-off, then rotated off.

Both still carry the standard GH secretagogue side effects — water retention, joint aches, blood-sugar effects, and hunger — on top of hexarelin's extra hormonal baggage.

A note for beginners: if this is your first GH peptide, this comparison should make the choice obvious. Start with ipamorelin (typically alongside CJC-1295), learn how your body responds to a clean GH pulse, and only consider specialist tools like hexarelin later, if ever, once you understand the category and have a specific reason. Reaching for the most potent option first is a classic mistake — it maximizes side effects and desensitization while teaching you the least about your own response. The GHRP comparison cluster is a good next stop for placing these two against the older GHRP-2 and GHRP-6 as well.

The bottom line

If you want one GH releasing peptide to run consistently for body composition and recovery, ipamorelin is the clear pick — it's clean, selective, sustainable, and beginner-friendly. Hexarelin is more powerful per dose, but it desensitizes fast and drags cortisol and prolactin up with it, which relegates it to short, specialized use for people who know exactly why they're reaching for it. Potency loses to sustainability here, which is exactly why ipamorelin became the community standard and hexarelin stayed a niche tool.

Related reading

• Why hexarelin desensitizes faster
• How ipamorelin replaced GHRP-2 and GHRP-6
• Ipamorelin protocol
• GHRP-2 vs GHRP-6 vs ipamorelin